Adverum Biotechnologies
ADVM
ADVM
116 hedge funds and large institutions have $693M invested in Adverum Biotechnologies in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.71% more ownership
Funds ownership: 7.6% → 9.31% (+1.7%)
13% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 38
Holders
116
Holding in Top 10
6
Calls
$13.5M
Puts
$3.69M
Top Buyers
| 1 | +$15.2M | |
| 2 | +$11.5M | |
| 3 | +$10.9M | |
| 4 |
Goldman Sachs
New York
|
+$7.03M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.14M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$14.3M | |
| 3 | -$6.77M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.64M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$3.17M |